These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38561604)
1. Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity. Dai Q; Zhu J; Yang J; Zhang CY; Yang WJ; Pan BS; Yang XR; Guo W; Wang BL Curr Stem Cell Res Ther; 2024 Mar; ():. PubMed ID: 38561604 [TBL] [Abstract][Full Text] [Related]
2. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment. Liu L; Zhang M; Cui N; Liu W; Di G; Wang Y; Xi X; Li H; Shen Z; Gu M; Wang Z; Jiang S; Liu B PLoS One; 2024; 19(4):e0298004. PubMed ID: 38635528 [TBL] [Abstract][Full Text] [Related]
3. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma. Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X Front Oncol; 2023; 13():1182434. PubMed ID: 37346073 [TBL] [Abstract][Full Text] [Related]
4. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Xu Q; Xu H; Chen S; Huang W Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040 [No Abstract] [Full Text] [Related]
5. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies. Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J Front Immunol; 2024; 15():1244392. PubMed ID: 38694506 [TBL] [Abstract][Full Text] [Related]
6. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival. Liu P; Dong C; Shi H; Yan Z; Zhang J; Liu J J Gastrointest Oncol; 2022 Dec; 13(6):3169-3182. PubMed ID: 36636051 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses. Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183 [TBL] [Abstract][Full Text] [Related]
8. Identification of hepatocellular carcinoma-related subtypes and development of a prognostic model: a study based on ferritinophagy-related genes. Wang G; Li J; Zhu L; Zhou Z; Ma Z; Zhang H; Yang Y; Niu Q; Wang X Discov Oncol; 2023 Aug; 14(1):147. PubMed ID: 37555866 [TBL] [Abstract][Full Text] [Related]
9. Construction of a novel mRNAsi-related risk model for predicting prognosis and immunotherapy response in osteosarcoma. Li Z; Jin C; Lu X; Zhang Y; Zhang Y; Wen J; Liu Y; Liu X; Li J Ann Transl Med; 2023 Jan; 11(2):61. PubMed ID: 36819514 [TBL] [Abstract][Full Text] [Related]
10. Profiles of Acetylation Regulation Genes Contribute to Malignant Progression and Have a Clinical Prognostic Impact on Liver Cancer. Zhu W; Zhang X; Yu M; Zhang Y; Li S; Yu C Dis Markers; 2022; 2022():1724301. PubMed ID: 36124029 [TBL] [Abstract][Full Text] [Related]
11. Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index. Bai KH; He SY; Shu LL; Wang WD; Lin SY; Zhang QY; Li L; Cheng L; Dai YJ Cancer Med; 2020 Jun; 9(12):4290-4298. PubMed ID: 32311840 [TBL] [Abstract][Full Text] [Related]
12. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer. Zhao X; Lin J Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313 [TBL] [Abstract][Full Text] [Related]
13. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma. Chen M; Wang X; Wang W; Gui X; Li Z Front Immunol; 2022; 13():829057. PubMed ID: 35833114 [TBL] [Abstract][Full Text] [Related]
14. Prognostic prediction using a gene signature developed based on exhausted T cells for liver cancer patients. Zhou Y; Wu W; Cai W; Zhang D; Zhang W; Luo Y; Cai F; Shi Z Heliyon; 2024 Mar; 10(6):e28156. PubMed ID: 38533068 [TBL] [Abstract][Full Text] [Related]
15. Integrative analysis unveils ECM signatures and pathways driving hepatocellular carcinoma progression: A multi-omics approach and prognostic model development. Liu Z; Zhao P J Cell Mol Med; 2024 Apr; 28(8):e18230. PubMed ID: 38568083 [TBL] [Abstract][Full Text] [Related]
16. Stem cell index-based RiskScore model for predicting prognosis in thyroid cancer and experimental verification. Chen R; Gao W; Liang L; Yu H; Song W Heliyon; 2024 Jun; 10(11):e31970. PubMed ID: 38868069 [TBL] [Abstract][Full Text] [Related]
17. Vesicle-mediated transport-related genes predict the prognosis and immune microenvironment in hepatocellular carcinoma. Ye Z; Wang Y; Yuan R; Ding R; Hou Y; Qian L; Zhang S J Cancer; 2024; 15(12):3645-3662. PubMed ID: 38911369 [No Abstract] [Full Text] [Related]
18. Identification of subtypes of hepatocellular carcinoma and screening of prognostic molecular diagnostic markers based on cell adhesion molecule related genes. Sun R; Gao Y; Shen F Front Genet; 2022; 13():1042540. PubMed ID: 36482887 [TBL] [Abstract][Full Text] [Related]
19. The Prognostic and Therapeutic Role of Histone Acetylation Modification in LIHC Development and Progression. Gao J; Han S; Gu J; Wu C; Mu X Medicina (Kaunas); 2023 Sep; 59(9):. PubMed ID: 37763801 [No Abstract] [Full Text] [Related]
20. A prognostic exosome-related long non-coding RNAs risk model related to the immune microenvironment and therapeutic responses for patients with liver hepatocellular carcinoma. Yue Y; Tao J; An D; Shi L Heliyon; 2024 Jan; 10(2):e24462. PubMed ID: 38293480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]